Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|January 28, 2004
Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responsesJacob Bukczynski, Tao Wen, Kim Ellefsen, et al.European Journal of Immunology|January 9, 2003
Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infectionsKim Ellefsen, Alexandre Harari, Patrick Champagne, et al.Vaccine|May 3, 2012
Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjectsEftyhia Vardas, Ioana Stanescu, Mika Leinonen, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2011
Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patientsOriol Manuel, Manuel Pascual, Katja Hoschler, et al.The Journal of Clinical Investigation|March 6, 2002
Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapyG Paolo Rizzardi, Alexandre Harari, Brunella Capiluppi, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 16, 2018
Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometryEvelina Cardoso, Thomas Mercier, Anna Dorothea Wagner, et al.Journal of Neuroinflammation|October 16, 2012
Carriers of the fragile X mental retardation 1 (FMR1) premutation allele present with increased levels of cytokine IL-10Diana Marek, Stephanie Papin, Kim Ellefsen, et al.Blood|August 1, 2002
Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infectionAlexandre Harari, G Paolo Rizzardi, Kim Ellefsen, et al.The Journal of Experimental Medicine|February 21, 2002
Thymic selection generates a large T cell pool recognizing a self-peptide in humansAlfred Zippelius, Mikaël J Pittet, Pascal Batard, et al.Cancer Treatment and Research Communications|December 21, 2024
Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural carcinosisLouis-Emmanuel Chriqui, Etienne Abdelnour-Berchtold, Edoardo Zanfrini, et al.Pageof 2